Search

everythinglearnresearchcommunity

for

Search:↓

NAFLD is common in women with PCOS and may signal metabolic syndrome.

Metabolic syndrome may increase the risk of small cell lung cancer.

Young males with severe early-onset hair loss may have a higher risk of metabolic syndrome.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

SH-SY5Y cell lysate is effective for diagnosing Satoyoshi syndrome.

Certain skin conditions can indicate a higher risk of diabetes and heart problems.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

A single steroid injection can cause serious side effects like Cushing Syndrome.

Sheehan syndrome can cause hormone deficiencies after childbirth, but treatment can improve symptoms.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

Trichotillomania is an obsessive-compulsive disorder causing hair pulling, needing complex treatment to prevent serious issues.

Early-onset male baldness may increase the risk of metabolic syndrome.

Androgenetic alopecia may be linked to metabolic syndrome.

Women with female pattern hair loss may have a higher risk of metabolic syndrome.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Finasteride and dutasteride may cause metabolic issues like liver disease and diabetes.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

Ganser syndrome may result from both organic and psychogenic factors.

Early treatment with corticosteroids improved her eye condition significantly.

Improved nutrition quickly healed the patient's skin lesions.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

Androgenetic alopecia may predict metabolic syndrome, so routine screening is recommended to prevent cardiovascular issues.

20% of patients with androgenic alopecia also had metabolic syndrome.

Cryptococcoid Sweet syndrome can be linked to hydralazine use and multiple autoantibodies, requiring high clinical suspicion and more research.

Minoxidil improved hair growth in a child with a rare genetic disorder.

Hair loss may indicate a higher risk of heart disease and other health issues related to metabolism.